United States · FDA National Drug Code directory
Benzonatate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-068_574a0b3f-6f57-4b39-e063-6294a90ad316
- Product NDC
- 85766-068
- Form
- CAPSULE
- Composition / generic term
- Benzonatate
- Labeler
- Sportpharm LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190222
- Source listing expiry
- 20271231
Source-listed ingredients
- BENZONATATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (85766-068-01) · 85766-068-01
- 500 CAPSULE in 1 BOTTLE (85766-068-05) · 85766-068-05
- 15 CAPSULE in 1 BOTTLE (85766-068-15) · 85766-068-15
- 20 CAPSULE in 1 BOTTLE (85766-068-20) · 85766-068-20
- 21 CAPSULE in 1 BOTTLE (85766-068-21) · 85766-068-21
- 30 CAPSULE in 1 BOTTLE (85766-068-30) · 85766-068-30
- 60 CAPSULE in 1 BOTTLE (85766-068-60) · 85766-068-60
- 90 CAPSULE in 1 BOTTLE (85766-068-90) · 85766-068-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →